← back to search

Mike A. Nalls

Alzheimer's Association · US
Area of research
Neurology · Genetics
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Genetic Associations and Epidemiology, Neurological diseases and metabolism, and Genomics and Rare Diseases.
h-index
86
citations
33,147
works
422
NIH funding
primary concept
Medicine
email

Recent publications

Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
npj Parkinson s Disease 2025cited by 5position: middledoi
Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD
Science Translational Medicine 2024cited by 153position: middledoi
<scp>NeuroBooster</scp> Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations
Movement Disorders 2024cited by 38position: middledoi
GenoTools: an open-source Python package for efficient genotype data quality control and analysis
G3 Genes Genomes Genetics 2024cited by 38position: lastdoi
African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1
Nature Structural & Molecular Biology 2024cited by 15position: middledoi
Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk
Nature Aging 2024cited by 14position: middledoi
A new AI-assisted data standard accelerates interoperability in biomedical research
medRxiv 2024cited by 4position: middledoi
A cellular taxonomy of the adult human spinal cord
Neuron 2023cited by 194position: middledoi
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study
The Lancet Neurology 2023cited by 151position: middledoi
Multi-ancestry meta-analysis and fine-mapping in Alzheimer’s disease
Molecular Psychiatry 2023cited by 81position: middledoi
Parallel CRISPR-Cas9 screens identify mechanisms of PLIN2 and lipid droplet regulation
Developmental Cell 2023cited by 64position: middledoi
Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson’s disease in Chinese population
npj Parkinson s Disease 2023cited by 64position: middledoi
The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism
Cell Genomics 2023cited by 51position: middledoi
Large-scale rare variant burden testing in Parkinson's disease
Brain 2023cited by 50position: middledoi
Genome‐Wide Analysis of Structural Variants in Parkinson Disease
Annals of Neurology 2023cited by 37position: middledoi
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
npj Parkinson s Disease 2023cited by 35position: middledoi
Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)
npj Parkinson s Disease 2023cited by 33position: middledoi
Artificial intelligence for dementia genetics and omics
Alzheimer s & Dementia 2023cited by 27position: middledoi
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Cell stem cell 2022cited by 293position: middledoi
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states
Nature Neuroscience 2022cited by 247position: middledoi
Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts
npj Parkinson s Disease 2022cited by 108position: middledoi
Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 Individuals Across 13 Cohorts
Diabetes Care 2022cited by 67position: middledoi
Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning
Molecular Psychiatry 2022cited by 20position: middledoi
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries
Nature 2022cited by 12position: middledoi
Stroke genetics informs drug discovery and risk prediction across ancestries
Research Square 2022cited by 10position: middledoi
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Nature Neuroscience 2021cited by 405position: middledoi
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications 2021cited by 213position: middledoi
Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
Movement Disorders 2021cited by 128position: middledoi
A reference induced pluripotent stem cell line for large-scale collaborative studies
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 13position: middledoi
Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans
JAMA Neurology 2020cited by 268position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew Singleton · University of Birmingham10 papers (2017–2023)Faraz Faghri · University of Illinois Urbana-Champaign5 papers (2021–2024)Cornelis Blauwendraat · National Institute for Public Health and the Environment5 papers (2021–2024)Hampton L. Leonard · Alzheimer's Association4 papers (2021–2024)Sayed Hadi Hashemi · University of Illinois Urbana-Champaign4 papers (2021–2023)Sara Bandrés‐Ciga · National Institute of Neurological Disorders and Stroke3 papers (2019–2023)Alastair J. Noyce · Queen Mary University of London3 papers (2017–2022)Martin Kampmann · University Memory and Aging Center3 papers (2021–2023)Dan Vitale · National Institute of Neurological Disorders and Stroke3 papers (2021–2024)Hirotaka Iwaki · National Institute of Neurological Disorders and Stroke3 papers (2021–2024)J. Raphael Gibbs · National Institutes of Health2 papers (2012–2021)Kun Leng · University of California, San Francisco2 papers (2021–2022)Gibran Hemani · University of Edinburgh2 papers (2017–2019)Kristin Levine · National Institute of Neurological Disorders and Stroke2 papers (2023–2024)John Hardy · Indiana University Bloomington2 papers (2012–2017)Zih‐Hua Fang · National Institute of Neurological Disorders and Stroke2 papers (2023–2024)Nina M. Dräger · University of California, San Francisco2 papers (2021–2022)Mary B. Makarious · Institute on Aging2 papers (2022–2024)Sonja W. Scholz · Johns Hopkins University2 papers (2021–2022)Peter Heutink · University of Tübingen2 papers (2023–2023)